Red Yeast Rice History Offers Blueprint For Clearing CBD As Dietary Ingredient

Legal dispute between FDA and Pharmanex decided in 1999 could be precedent for using hemp-derived ingredients including CBD in supplements, even though CBD already has been authorized for clinical drug evaluation and for use in a drug, says attorney Miriam Guggenheim.

cannabis CBD oil hemp products - Image

Litigation decided in 1999 that challenged the US Food and Drug Administration’s policy against using red yeast rice extract as a dietary ingredient could be a roadmap to convincing the agency to change its policy against cannabidiol's use in dietary supplements and food.

The legal battle between the agency and supplement marketer Pharmanex Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation